In today’s competitive environment the reduction of the time taken to reach the market is critical to a product’s and hence the company’s success. The proper conduct of its Regulatory Affairs activities is therefore of considerable economic importance for the company.
Regulatory Affairs have been developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines.
The companies responsible for the discovery, testing, manufacture and marketing of these products also want to ensure that they supply products that are safe and make a worthwhile contribution to public health and welfare.
Most companies, whether they are major multinational pharmaceutical corporations or SME, innovative biotechnology companies, have specialist groups of Regulatory Affairs professionals – and those who don’t have one inhouse they rely on the expert advice of independent regulatory consultants to meet their obligations.
NUVO keeps a track of the ever-